FDA says breast cancer drug did not extend lives
Friday, July 16, 2010 - 11:35
in Health & Medicine
(AP) -- Federal health scientists said Friday that follow-up studies of a Roche breast cancer drug show it failed to slow tumor growth or extend patient lives, opening the door for a potential withdrawal in that indication.